Fundraising FoxHarbor Medtech
Irvine, US · Founded 2010 · Delaware corporation · 2 known investors
Find your way into Harbor Medtech
Sign up to see every warm intro you have to Harbor Medtech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Harbor Medtech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Harbor MedTech develops collagen-based medical devices and bioimplants for surgical wound healing and tissue regeneration. The company's BriDGE technology platform produces products for orthopedic, general surgical, and chronic wound care applications.
Founders & leadership
WJ
W. Jerome MezgerExecutive
WJ
William Jerome MezgerExecutive
Board
JC
Jay ChamplainBoard director
JJ
James J. JungwirthBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$6M disclosed across 3 rounds · 2012–2017
▶$250KraisedOct 2017 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedOct 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William Jerome MezgerExecutive Officer, Director
- Jay ChamplainDirector
- Peter ReineckeDirector
- Offering amount
- $8M
- Amount sold
- $250K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.1MraisedNov 2016 · 4 investors · Other Health CareRule 506(b)
▶$5.1MraisedNov 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jay ChamplainDirector
- W. Jerome MezgerExecutive Officer, Director
- Offering amount
- $8.5M
- Amount sold
- $5.1M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$669.7KraisedFeb 2012 · 10 investors · Other Health CareRule 506(b)
▶$669.7KraisedFeb 2012 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James J. JungwirthDirector
- Jay ChamplainDirector
- William Jerome MezgerExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $669.7K
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
OrganogenesisOrganogenesis is a regenerative medicine company that develops and commercializes products for the advanced wound care and surgical biologics markets, supplying clinicians and their patients. Its product portfolio includes tissue-based therapies such as Apligraf for wound care.
Companies working in the same space as Harbor Medtech.
Frequently asked questions
- What does Harbor Medtech do?
- Harbor MedTech develops collagen-based medical devices and bioimplants for surgical wound healing and tissue regeneration. The company's BriDGE technology platform produces products for orthopedic, general surgical, and chronic wound care applications.
- Who are Harbor Medtech's investors?
- Harbor Medtech's investors include Alumni Ventures, Bascom Ventures.
- How much funding has Harbor Medtech raised?
- Harbor Medtech has disclosed $6M raised across 3 rounds.
- Where is Harbor Medtech headquartered?
- Harbor Medtech is headquartered in Irvine, US.